Home > Drug Search >
  • company_query: BerGenBio
  •   > 
Drug Filter
Category:
chemistry (25) biology (8)
Status:
Approved (2) NDA Filing (2) Phase Ⅲ (6) Phase Ⅱ (18) Phase Ⅰ (4)
Clinical Stage:
Pending (3) Active (21) Discontinued (7)
Bio-Type:
CAR T cell therapy (2) Recombinant cytokines (2) Whole antibody (2) ADC (1)
Indication:
Acne (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (4) Allergic conjunctivitis (1) Anemia (3) Atopic dermatitis (2) Bladder cancer (1) Breast cancer (1) Chronic myeloid leukemia (CML ) (1) Crohn's disease (1) Epilepsy/Seizures (1) Follicular lymphoma (1) Glioblastoma multiforme (1) HCV infection (1) Hepatocellular carcinoma (HCC) (2) HIV infection (2) Leukemia (1) Lymphoma (3) Malignancies (1) Renal osteodystrophy (1) Melanoma (4) Multiple myeloma (MM) (3) Myelodysplastic syndrome (MDS) (2) Non small cell lung cancer (NSCLC) (4) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (1) Pancreatic cancer (3) Prostate cancer (2) Psoriasis (1) Rheumatoid arthritis (RA) (1) Solid tumours (4) Ulcerative colitis (1) Head and neck cancer (2) Colorectal cancer (2) Fallopian tube cancer (1) Epithelial ovarian cancer (1) Colon cancer (1) Waldenström's macroglobulinemia (WM) (1) Renal carcinoma (1) Peritoneum cancer (1) Myelodysplasia (1) Glioma (1) Ischemia-reperfusion injury (1) Gingival diseases (1) Chronic myelomonocytic leukemia(CMML) (1) Diffuse large B cell lymphoma (1) Thelassemia (1) Musculoskeletal pain (1) Vascular calcification (1) Stomatitis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top